Technetium (99mTc) votumumab

Technetium (^99mTc) votumumab (trade name HumaSPECT) is a human monoclonal antibody labelled with the radionuclide technetium-99m.^[1][2] It was developed for the detection of colorectal tumors, but has never been marketed.^[3]

Technetium (^99mTc) votumumab

Monoclonal antibody
Type	Whole antibody
Source	Human
Target	tumor antigen CTAA16.88
Clinical data
ATC code	V09IA04 (WHO)
Legal status
Legal status	not marketed
Identifiers
CAS Number	148189-70-2 N
ChemSpider	none
UNII	63635D7SGF
NY (what is this?)  (verify)

The target of votumumab is CTAA16.88, a complex of cytokeratin polypeptides in the molecular weight range of 35 to 43 kDa, which is expressed in colorectal tumors.^[4]